Teva Pharmaceuticals and Medincell recently announced that the FDA has approved UZEDY® (risperidone), a once-monthly ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street ...

The once-a-month extended-release injectable suspension incorporates Medincell's copolymer technology. Credit: ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...

Despite these encouraging fundamental developments, Teva shares continue to face investor skepticism, remaining down nearly 20% since the beginning of the year. Technical indicators present a mixed ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 9, ...

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue ® , a biosimilar to Herceptin ® ...

JERUSALEM — Teva on Tuesday confirmed its receipt of an action letter from the Food and Drug Administration for its generic blood-thinning drug. The drug maker said the FDA sent a minor deficiency ...

Viatris' dividend yield is 4.93%, while Teva hasn't paid dividends since 2017. Thus, summing up this information, Viatris is ...